Get started
Markets Canada Stocks Health Technology Medical Specialties

IZOTROPIC CORPORATION IZO

IZOCSE
IZO
IZOTROPIC CORPORATIONCSE
See more on advanced chartSee more on advanced chart
 
No trades
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
Upcoming Earnings
EPS
Market Cap
Div Yield
P/E
See more on advanced chartSee more on advanced chart
Overview
News Ideas Financials Technicals

IZO chart

Ideas

IZO:CSE - Izotropic Corporation: Inverse head and shoulders
IZO
, 1DLong
IZO: IZO:CSE - Izotropic Corporation: Inverse head and shoulders

IZO:CSE - Izotropic Corporation: After a strong 950% move last July- October, Izotopic stock has consolidated in a healthy range for over 120 days (nearly 6 months). In the last two months the stock has formed a nearly textbook Inverse head and shoulders pattern, potentially signalling a next leg higher coming in the near term. Fundamentals for the company...

Technicals

Financials

Valuation
Enterprise Value/EBITDA, TTM —
Enterprise Value, FQ —
Market Cap — Basic —
Number of Employees —
Number of Shareholders —
Price/Earnings, TTM —
Price/Revenue, TTM —
Price/Book Ratio, FY —
Price/Sales Ratio, FY —
Balance Sheet
Current Ratio, FQ —
Debt to Equity, FQ —
Net Debt, FQ —
Quick Ratio, FQ —
Total Assets, FQ —
Total Debt, FQ —
Operating Metrics
Return on Assets, TTM —
Return on Equity, TTM —
Return on Invested Capital, TTM —
Revenue per Employee, TTM —
Price History
Average Volume (10 day) —
Beta - 1 Year —
Price - 52 Week High —
Price - 52 Week Low —
Dividends
Dividends Paid, FY —
Dividends per Share, FY —
Expected Annual Dividends —
Dividends Yield —
Margins}
Net Margin, TTM —
Gross Margin, TTM —
Operating Margin, TTM —
Pretax Margin, TTM —
Income Statement
Basic EPS, Net Income —
Earnings per Share, Basic, TTM —
EBITDA, TTM —
Gross Profit, FY —
Last Annual EPS —
Last Annual Revenue, FY —
Net Income, FY —
Total Revenue, FY —
Free Cash Flow, TTM —
More financials

Profile

Sector: Health Technology
Industry: Medical Specialties
Izotropic Corp. engages in the commercialization of proprietary diagnostic products for breast cancer. It involves in the import and sale of products & services in the field of human diagnostics and therapeutics in the United States. The company was founded by John M. Boone on May 19, 2016 and is headquartered in Surrey, Canada.

News flow

More news